Okay. I think we’re ready to get started with the next presentation. Coming to the stage now we have Hansen Medical. And presenting for them is Bruce Barclay, their President and CEO. We’ll take questions mainly afterwards in the Yorkshire room. Bruce. Bruce Barclay Thanks Chris, good morning everybody. Thanks for being here this morning. We’re happy to be here. With me this morning is Pete Mariani, Pete is our Chief Financial Officer and you’ll hear him. And he’ll be available to Q&A here following the prepared remarks. I will be making forward-looking statements this morning. I would encourage you to read the information in this slide and also in our Securities filings as they contain important information. So, Hansen Medical is a leading provider of flexible robotics. We believe poised for growth in the $1 billion plus medical robotics market. We very much believe flexible robotics is a platform technology. We have chosen though to focus ourselves on two key clinical areas. First is Electrophysiology or EP for short and the second is the Vascular Opportunity. First in Electrophysiology, we sell the product called the Sensei Robotic system, we’ve been selling that system in the US and Europe since 2007. We have a growing clinical utilization having conducted more than 7,000 procedures with that system in patients around the world. And that clinical utilization is growing every month.